Publication | Open Access

Clinical usefulness of PI3K/Akt/mTOR genotyping in companion with other clinical variables in metastatic renal cell carcinoma patients treated with everolimus in the second and subsequent lines

UrologyRenal FunctionGenitourinary CancerMedicineSubsequent LinesPathologyOther Clinical VariablesClinical UsefulnessOncology